Abstract:OBJECTIVE:To study the impact of small interference RNA (siRNA) targeting cyclin A2 gene on the growth of MG-63 and HSF cells and to explore whether cyclin A2 siRNAs could become a useful tool in the treatment of osteosarcoma.METHODS:One pair of siRNA targeting the cyclin A2 mRNA and a pair of nonsense siRNA were designed according the current criteria. SiRNA was chemically synthesized and purified. The siRNA was transfected into osteosarcoma cell line MG-63 and normal human skin fibroblast (HSF) cells via oligofectamine. Cells transfected with nonsense siRNA served as the negative control and those only treated with PBS as the blank control group. Quantitative fluorescence RT-PCR, Western-blot, MTT assay, reverse transcriptase (RT)-PCR, flow cytometry and colony-forming test were employed to evaluate the efficacy of RNA interference. At the same time, the mRNA expression of PCNA and cyclin B1 in siRNA treated MG-63 cells were examined.RESULTS:1 nmol/L, 10 nmol/L, 50 nmol/L and 100 nmol/L cyclin A2-siRNA can reduced cyclin A2 mRNA and protein expression respectively by 9.43%, 56.35%, 79.17% and 84.30% as compared with that of the blank control group, whereas the negative and blank control groups had similar expression levels. After 48 h treatment with 10 nmol/L siRNA, MG-63 cells were arrested in G0/G1 phase and the proliferation of this tumor cell was suppressed by 39.06% 48 h after transfection. Furthermore, the treated MG-63 cells showed less colony-forming ability. Increasing the siRNA concentration to 50 nmol/L can further inhibit the proliferation of MG-63 cells by 54.94%. In addition, the cyclin A2-depleted MG-63 cells showed decreased levels of PCNA and cyclin B1. In contrast, although cyclin A2 mRNA and protein expression in HSF reduced 58.13% 48 h after treatment by 50 nmol/L siRNA, these cells exhibited only a slight change in cell cycle, and no clear inhibition of proliferation and impaired plate colony-forming ability was observed.CONCLUSION:Cyclin A2 gene maybe served as a potential target for tumor therapy. RNA interference induces obvious inhibition of cyclin A2 mRNA and protein expression in MG-63 and HSF cells, which consequently downregulate the proliferation of MG-63 cells. There is few inhibitory effect on the proliferation by siRNAs for HSF cells. These results indicate that siRNAs against cyclin A2 could become a potential antiproliferative tool in future antitumor therapy.

[Therapeutic Effects of Small Interfering RNA Targeting MDM2 on Human Osteosarcoma Cells].

microRNA-486 suppressed proliferation , migration and invasion of osteosarcoma cells via directly targeting SIRT 1

MicroRNA-211 inhibits tumor growth and invasion through directly targeting RUNX 2 in osteosarcoma

Inhibitory effects of siRNA on MDM2 expression and cell proliferation in osteosarcoma cell line

Hsa-miR-557 Inhibits Osteosarcoma Growth Through Targeting KRAS

[Knockdown of Cyclin A2 Expression by Small Interfering RNA in MG-63 Cells].

[Growth Inhibition of MG-63 Cells by Cyclin A2 Gene-Specific Small Interfering RNA].

Silencing of Glucose Transporter Protein-1 by Rna Interference Inhibits Human Osteosarcoma Mg63 Cells Growth in Vivo

MicroRNA-133a Inhibits Osteosarcoma Cells Proliferation and Invasion Via Targeting IGF-1R

Inhibiting the proliferation of osteosarcoma 143B cell by blocking the MIF gene with siRNA

MicroRNA-455-3p Inhibits Osteosarcoma Progression Via HSF1 Downregulation

Effects of Id1 Knockdown by Small Interfering RNA on Cell Proliferation, Migration and Apoptosis of Murine Osteosarcoma Cell

Microrna-194 Suppresses Osteosarcoma Cell Proliferation and Metastasis in Vitro and in Vivo by Targeting CDH2 and IGF1R.

Effects of combined c-myc and Bmi-1 siRNAs on the growth and chemosensitivity of MG-63 osteosarcoma cells.

[Effect of EPHA2-siRNA Plasmid on Biological Behavior of Human Osteosarcoma Cells in Vitro].

MiR-34a Inhibits Cell Proliferation and Migration in Osteosarcoma by Downregulating DNMT1

Survivin-targeted Sirna Inhibits Proliferation of Human Osteosarcoma Cell Line MG63 in Vitro and in Vivo

Therapeutic effects of RNA interference targeting HIF-1 alpha gene on human osteosarcoma]

MicroRNA-22 Inhibits the Proliferation and Migration, and Increases the Cisplatin Sensitivity, of Osteosarcoma Cells

Expression and Regulatory Effects of Microrna-182 in Osteosarcoma Cells: A Pilot Study

MiR-92a modulates proliferation, apoptosis, migration and invasion of osteosarcoma cell lines by targeting Dickkopf-related protein 3.